Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients.
Both parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained.
NAMSA ® Acquires Syntactx to Enhance End-to-End CRO Development Solutions, Expanding Medical Device Clinical Research Capabilities and Expertise
“Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device development and clinical research services,” stated Dr. Kenneth Ouriel, President and CEO of Syntactx.
Exact Sciences Completes Acquisition of Thrive Earlier Detection: Blood-Based Multi-Cancer Screening Becomes a Reality & Eventually the Standard of Care Notes CEO
Chairman and CEO Kevin Conroy said, "Bringing Thrive into the Exact Sciences family marks a giant leap toward blood-based, multi-cancer screening becoming a reality and eventually the standard of care.
Founded in 1999, Degradable Solutions AG, is headquartered in Schlieren, Switzerland, and has been part of the Sunstar Group since 2011.
December 28, 2020 United Therapeutics Corporation announced today an agreement to acquire a Rare Pediatric Disease Priority Review Voucher (PRV), which it plans to use with a forthcoming New Drug Application with the U.S. Food and Drug Administration. United...
The acquisition of Pacific Stem Cells, LLC would further expand Dalrada Health's product and services offerings in the healthcare industry.
"With eMDs, we are taking our US business to a new dimension. Know-how, products, and target markets excellently complement one another," said Frank Gotthardt, founder and CEO of CompuGroup Medical SE & Co. KGaA. The Group, with its headquarters in Germany, is one of the world's leading providers of eHealth solutions.